MedTrace Logo

Comparison of Prostate Fusion Biopsies With Software and Cognitive

NCT04291742 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 804

Last updated 2020-03-02

No results posted yet for this study

Summary

This study evaluates the efficacy to diagnose significant prostate cancer in patients with suspicious lesions in mpMRI (multiparametric magnetic resonance imaging) by comparing prostate biopsies performed by cognitive fusion with respect to those performed with software fusion (BK-fusion®). Half of the patients included will undergo a systematic prostate biopsy + target biopsies by cognitive fusion and the other half of the population, will undergo a systematic prostate biopsy + target biopsies by software fusion.

Conditions

  • Prostate Cancer Detection
  • Fusion Prostate Biopsy

Interventions

DIAGNOSTIC_TEST

cognitive vs software

cognitive vs software

Sponsors & Collaborators

  • Hospital Universitari Vall d'Hebron Research Institute

    lead OTHER

Principal Investigators

  • Ana Celma, MD · Hospital Vall d'Hebron, Barcelona

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-16
Primary Completion
2022-02-27
Completion
2022-02-27

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04291742 on ClinicalTrials.gov